Study Indication and Rationale, Theory of Mechanism of Operation, & Supporting Materials


The Resonator™ device uses electro-magnetic stimulation in order to relieve symptoms of a disorder or disease.


 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

 
 
 
 
   
   


Current Research

The following is a collection of research studies that are in progress or planned pertaining to the application of electromagnetic stimulation for the relief of Parkinson's disease symptoms.

  1. Phase 1 Study of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease
    Sponsored by: Assistance Publique - Hôpitaux de Paris
    Rationale for Study: Advanced stage of Parkinson disease (PD) is a difficult condition to treat, especially after several years of dopaminergic drugs. Recent development of neurosurgical techniques using deep brain stimulation leads has shown good behavioral results in these advanced PD patients. However, the placement of a stimulation lead in the subthalamic nucleus is a complex, invasive, and long surgical procedure. Such intervention requires sophisticated technical environment, including stereotactic MRI exam, associated with per-operative electrophysiological exploration of deep brain structures. This surgical treatment can therefore be indicated only for a few selected patients, and can not be offered to a large proportion of patients among the potential candidates. Thus, there is a need to develop therapeutic alternatives that would be technically and practically more convenient, less invasive, and that could be offered to a larger number of patients. Several clinical studies, including one led by this group, have already demonstrated that transcranial magnetic cortical stimulation could improve bradykinesia and shorten motor reaction time in patients with Parkinson disease. In non-human primate model of late stage Parkinson disease, it has been demonstrated that prolonged primary motor cortex stimulation significantly improved both akinesia and bradykinesia.

    The expected benefit for the patient will be gait improvement, increase movement velocities, and finally a better quality of life associated with reduction in dopaminergic medication.


 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.

 
 

Physicians located in Oakland, Wayne, and Macomb County of Michigan, who have patients living with Parkinson’s disease, should know that Pico-Tesla Magnetic Therapies are currently conducting clinical trials. These trails will be used to test the efficacy of the Resonator® device which uses pulsed magnetic field therapy in treating Parkinson’s patients. This is a paid clinical trial for all patients who qualify for and complete the procedure.

Pico-Tesla is holding these clinical trials in their Novi, MI office. Novi is located in southeast Michigan, just 30 minutes northwest of Detroit. Any interested party can contact Pico-Tesla for more information.